[QODLink]
people & power
Drug money
People & Power investigates fraud and corruption in the US pharmaceutical industry.
Last Modified: 29 Aug 2010 17:04 GMT

 

The US healthcare industry is the world's biggest, with $300bn per year spent on prescription drugs.
 
For many these drugs have brought undeniable benefits.
 
But recent months have seen health scandal after health scandal making headlines in the US.

Two of the world's biggest pharmaceutical companies have been fined billions of dollars after investigations into their secret working practices.
 
What these cases have revealed will change the way the drug industry is perceived forever.

Revelations have emerged of pervasive fraud, fatal side effects, and huge kick-backs paid to doctors.
 
This investigation by Melanie Newman and Chris Woods reveals how healthcare became unhealthy profit.

This episode of People & Power airs from Wednesday, August 11, at the following times: Wednesday: 0600, 1230; Thursday: 0130, 1400, 1930; Friday: 0630, 1630; Saturday: 0330, 2030; Sunday: 0030, 0530; Monday: 0830.

Source:
Al Jazeera
Topics in this article
People
Country
Featured on Al Jazeera
The author argues that in the new economy, it's people, not skills or majors, that have lost value.
Colleagues of detained Al Jazeera journalists press demands for their release, 100 days after their arrest in Egypt.
Mehdi Hasan discusses online freedoms and the potential of the web with Wikipedia founder Jimmy Wales.
A tight race seems likely as 814 million voters elect leaders in world's largest democracy next week.
Featured
Iran's government has shifted its take on 'brain drain' but is the change enough to reverse the flow?
Deadly attacks on anti-mining activists in the Philippines part of a global trend, according to new report.
Activists say 'Honor Diaries' documentary exploits gender-based violence to further an anti-Islamic agenda.
As Syria's civil war escalates along the Turkish border, many in Turkey are questioning the country's involvement.
Treatment for autism in the region has progressed, but lack of awareness and support services remains a challenge.
join our mailing list